$Prognostic and predictive value of blood eosinophil count, fractional exhaled nitric oxide and their combination in severe asthma: a post-hoc analysis$

Prognostic and predictive value of blood eosinophil count, fractional exhaled nitric oxide and their combination in severe asthma: a post-hoc analysis

Bibliográfalaš dieđut
Váldodahkkit:	Shrimanker, R, Keene, O, Hynes, G, Wenzel, S, Yancey, S, Pavord, I
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	American Thoracic Society 2019

Geahča maid

Fractional exhaled nitric oxide and the peripheral blood eosinophil count as biomarkers of the response to mepolizumab in patients with severe eosinophilic asthma
Dahkki: Shrimanker, R, et al.
Almmustuhtton: (2018)

Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
Dahkki: Price, D, et al.
Almmustuhtton: (2019)

Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
Dahkki: David B. Price, et al.
Almmustuhtton: (2019-08-01)

Diagnostic possibility of the combination of exhaled nitric oxide and blood eosinophil count for eosinophilic asthma
Dahkki: Jiang-Hua Li, et al.
Almmustuhtton: (2021-08-01)

Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
Dahkki: Howell, I, et al.
Almmustuhtton: (2024)

Biomarkers for severe eosinophilic asthma.
Dahkki: Yancey, S, et al.
Almmustuhtton: (2017)

Treatment Resistance in Severe Asthma Patients With a Combination of High Fraction of Exhaled Nitric Oxide and Low Blood Eosinophil Counts
Dahkki: Yuki Hoshino, et al.
Almmustuhtton: (2022-04-01)

Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
Dahkki: Imran Howell, et al.
Almmustuhtton: (2024-07-01)

Does a composite score combining peripheral blood eosinophils (PBE) and exhaled nitric oxide (FeNO) accurately predict a sputum eosinophilia?
Dahkki: Connolly, CM, et al.
Almmustuhtton: (2017)

Both fractional exhaled nitric oxide and sputum eosinophil were associated with uncontrolled asthma
Dahkki: Gao J, et al.
Almmustuhtton: (2018-04-01)

Fractional exhaled nitric oxide and eosinophil count in induced sputum to guide the management of children with asthma: a cost-utility analysis
Dahkki: Buendía, JA, et al.
Almmustuhtton: (2022)

Fractional exhaled nitric oxide and eosinophil count in induced sputum to guide the management of children with asthma: a cost-utility analysis
Dahkki: Jefferson Antonio Buendía, et al.
Almmustuhtton: (2022-06-01)

The use of exhaled nitric oxide in the management of asthma.
Dahkki: Pavord, I, et al.
Almmustuhtton: (2008)

IL-5 antagonism reverses priming and activation of eosinophils in severe eosinophilic asthma
Dahkki: Luo, J, et al.
Almmustuhtton: (2024)

Long-Term Adjustment of Stable Asthma Treatment with Fractional Exhaled Nitric Oxide and Sputum Eosinophils
Dahkki: M. Malerba, et al.
Almmustuhtton: (2012-09-01)

Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide
Dahkki: Couillard, S, et al.
Almmustuhtton: (2021)

The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma.
Dahkki: Berry, M, et al.
Almmustuhtton: (2005)

Evaluation of potential continuation rules for mepolizumab treatment of severe eosinophilic asthma.
Dahkki: Gunsoy, N, et al.
Almmustuhtton: (2017)

Management and mechanisms of severe eosinophilic asthma
Dahkki: Shrimanker, R
Almmustuhtton: (2020)

Annual Fractional Exhaled Nitric Oxide Measurements and Exacerbations in Severe Asthma
Dahkki: Abe Y, et al.
Almmustuhtton: (2020-12-01)

Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma.
Dahkki: Bel, E, et al.
Almmustuhtton: (2014)

Association between fractional exhaled nitric oxide, sputum induction and peripheral blood eosinophil in uncontrolled asthma
Dahkki: Jie Gao, et al.
Almmustuhtton: (2018-05-01)

Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysis
Dahkki: Charlene M. Prazma, et al.
Almmustuhtton: (2019-05-01)

Meta-analysis of asthma-related hospitalization in mepolizumab studies of severe eosinophilic asthma
Dahkki: Yancey, S, et al.
Almmustuhtton: (2016)

Will exhaled nitric oxide monitoring become routine in managing asthma?
Dahkki: Pavord, I, et al.
Almmustuhtton: (2009)

Mepolizumab treatment in patients with severe eosinophilic asthma.
Dahkki: Ortega, H, et al.
Almmustuhtton: (2014)

Fractional exhaled nitric oxide non-suppression in asthma
Dahkki: Couillard Castonguay, S
Almmustuhtton: (2021)

Measurements of fractional exhaled nitric oxide in pediatric asthma
Dahkki: Youn-Soo Hahn
Almmustuhtton: (2013-10-01)

The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre
Dahkki: Shrimanker, R, et al.
Almmustuhtton: (2017)

Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies.
Dahkki: Ortega, H, et al.
Almmustuhtton: (2016)

The effect of oral corticosteroids on circulating type-2 cytokine producing cells in patients with severe eosinophilic asthma
Dahkki: Hynes, G, et al.
Almmustuhtton: (2018)

Benralizumab in severe eosinophilic asthma in real life: confirmed effectiveness and contrasted effect on sputum eosinophilia versus exhaled nitric oxide fraction – PROMISE
Dahkki: Florence Schleich, et al.
Almmustuhtton: (2023-11-01)

A novel CT scoring system differentiates admissions secondary to eosinophilic from non-eosinophilic asthma
Dahkki: Hynes, G, et al.
Almmustuhtton: (2017)

Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
Dahkki: Steven W. Yancey, et al.
Almmustuhtton: (2019-09-01)

Fractional exhaled Nitric Oxide monitoring in paediatric asthma management
Dahkki: Jones, N, et al.
Almmustuhtton: (2017)

Fractional Exhaled Nitric Oxide (FeNo) in Different Asthma Phenotypes
Dahkki: Bilun Gemicioglu M.D. Ph.D., et al.
Almmustuhtton: (2014-09-01)

The Fraction Exhaled Nitric Oxide as a Biomarker of Asthma Control
Dahkki: Fernanda Cruvinel de Abreu, et al.
Almmustuhtton: (2019-01-01)

Predictive Value of Exhaled Nitric Oxide and Blood Eosinophil Count in the Assessment of Airway Eosinophilia in COPD
Dahkki: Antus B, et al.
Almmustuhtton: (2020-08-01)

Exhaled nitric oxide in the diagnosis of asthma in adults: a systematic review.
Dahkki: Harnan, S, et al.
Almmustuhtton: (2017)

Relationship between fraction of exhaled nitric oxide and peripheral eosinophilia in asthma
Dahkki: Jane S. Afriyie-Mensah, et al.
Almmustuhtton: (2024-12-01)